Overestimation of free light chain antigen excess rate
- 1 April 2015
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 444, 297-302
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaHematology/Oncology Clinics of North America, 2014
- Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosusLupus, 2014
- Monoclonal gammopathy related to Sjögren syndrome: A key marker of disease prognosis and outcomesJournal of Autoimmunity, 2012
- Effect of sample dilution on serum free light chain concentration by immunonephelometric assayClinica Chimica Acta, 2011
- Normalization of serum-free light chains in patients with systemic lupus erythematosus upon rituximab treatment and correlation with biological disease activityClinical Rheumatology, 2011
- Detection of serum free light chains: the problem with antigen excessClinical Chemistry and Laboratory Medicine (CCLM), 2010
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementLeukemia, 2010
- Sharply Increased Serum Free Light-Chain Concentrations after Treatment for Multiple MyelomaClinical Chemistry, 2010
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersLeukemia, 2008
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005